Harrow Health (HROW) Stock Statistics & Valuation Metrics

Harrow Health has a market cap or net worth of $1.06B. The enterprise value is $1.80B.

Market Cap

$1.06B

Enterprise Value

$1.80B

Harrow Health has 37,487,850 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

37,487,850

Owned by Insiders

19.99%

Owned by Institutions

27.05%

Harrow Health’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is 12.70%.

Return on Equity (ROE)

-0.10

Return on Assets (ROA)

-0.01

Return on Invested Capital (ROIC)

12.70%

Return on Capital Employed (ROCE)

0.13

Revenue Per Employee

730.03K

Profits Per Employee

-13.78K

Employee Count

373

Asset Turnover

0.68

Inventory Turnover

5.02

The current PE Ratio of Harrow Health is -28.76. Harrow Health’s PEG ratio is 0.53.

PE Ratio

-28.76

PS Ratio

3.88

PB Ratio

70.13

Price to FCF

188.16

Price to Operating Cash Flow

170.50

PEG Ratio

0.53

In the last 12 months, Harrow Health had revenue of 272.30M and earned -5.14M in profits. Earnings per share was -0.14.

Revenue

272.30M

Gross Profit

204.37M

Operating Income

38.61M

Pretax Income

-1.72M

Net Income

-5.14M

EBITDA

42.13M

Earnings Per Share (EPS)

-0.14

In the last 12 months, operating cash flow was 6.25M and capital expenditures -566,000, giving a free cash flow of 5.69M billion.

Operating Cash Flow

6.25M

Free Cash Flow

5.69M

Free Cash Flow per Share

0.15

Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

0.53%

Earnings Yield

-3.50%

Beta

2.08

52-Week Price Change

-20.63%

50-Day Moving Average

32.81

200-Day Moving Average

38.21

Relative Strength Index (RSI)

41.02

Average Volume (3m)

581.65K

Harrow Health upcoming earnings date is Nov 09, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 10, 2026

Next Earnings Date

Nov 09, 2026

Ex-Dividend Date

―

Harrow Health as a current ratio of 2.20, with Debt / Equity ratio of 480.45%

Current Ratio

2.20

Quick Ratio

2.06

Debt to Market Cap

0.14

Net Debt to EBITDA

4.25

Interest Coverage Ratio

1.60

In the past 12 months, Harrow Health has paid 3.42M in taxes.

Income Tax

3.42M

Effective Tax Rate

-1.98

Harrow Health EV to EBITDA ratio is 114.74, with an EV/FCF ratio of 225.74.

EV to Sales

4.66

EV to EBITDA

114.74

EV to Free Cash Flow

225.74

EV to Operating Cash Flow

205.31

Harrow Health has $83.89M in cash and marketable securities with $300.74M in debt, giving a net cash position of -$216.85M billion.

Cash & Marketable Securities

$83.89M

Total Debt

$300.74M

Net Cash

-$216.85M

Net Cash Per Share

-$5.78

Tangible Book Value Per Share

-$4.35

Gross margin is 73.28%, with operating margin of 2.07%, and net profit margin of -13.51%.

Gross Margin

73.28%

Operating Margin

2.07%

Pretax Margin

-12.13%

Net Profit Margin

-13.51%

EBITDA Margin

4.06%

EBIT Margin

-3.79%

The average price target for Harrow Health is $64.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$64.33

Price Target Upside

125.41% Upside

Analyst Consensus

Strong Buy

Analyst Count

8

Revenue Growth Forecast

21.05%

EPS Growth Forecast

-244.96%

Smart Score

6

AI Score

48